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The discovery within the past decade that neural stem cells (NSCs) from the developing and adult mammalian brain can
be propagated, cloned, and genetically manipulated ex vivo for ultimate transfer back into the CNS has opened the door to
a novel means for modifying the CNS environment for experimental and therapeutic purposes. While a great deal of interest
has been focused on the properties and promise of this new technology, especially in regard to cellular replacement and
gene therapy, this minireview will focus on the recent use of NSCs to study the neuropathogenesis of the murine
oncornaviruses. In brief, the use of this NSC-based approach has provided a means for selective reconstitution within the
brain, of specific retroviral life cycle events, in order to consider their contribution to the induction of neurodegeneration.
Furthermore, by virtue of their ability to disseminate virus within the brain, NSCs have provided a reliable means for
assessing the true neurovirulence potential of murine oncornaviruses by directly circumventing a restriction to virus entry
into the CNS. Importantly, these experiments have demonstrated that the neurovirulence of oncornaviruses requires late
virus life cycle events occurring specifically within microglia, the resident macrophages of the brain. This initial application
of NSC biology to the analysis of oncornavirus–CNS interactions may serve as an example for how other questions in viral
neuropathogenesis might be addressed in the future. © 2000 Academic Press
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lPROPERTIES OF NEURAL STEM CELLS
NSCs are immature, uncommitted cells that exist in
he developing and adult nervous system and give rise to
he vast array of more specialized neural cells of the CNS
reviewed in McKay, 1997; Snyder, 1998). They are oper-
tionally defined by their ability to self-renew, to differ-
ntiate into cells of most (if not all) neuronal and neuro-
lial lineages, and to populate developing and degener-
ting regions of the CNS.
Several properties make NSCs attractive tools for in-
estigating the biology and pathology of the CNS. NSCs
re readily isolated and expanded in culture using spe-
ific growth factor combinations or via the introduction of
conditional immortalizing gene, for example, v-myc or
emperature-sensitive SV40 large T antigen (reviewed in
artinez-Serrano and Bjorklund, 1997). Alternatively,
SCs can be derived from embryonic stem cells (ES
ells) through a series of in vitro differentiation proce-
ures involving growth factor exposure and substrate
ttachment (see for example Brustle et al., 1997). Unlike
emopoietic stem cells, NSC clones usually have short
oubling times, often less than 18 h, allowing rapid
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227xpansion of selected populations after genetic modifi-
ation. Genetic manipulation of NSCs can be accom-
lished using a variety of transfection and infection tech-
iques, and this alteration appears to have little effect on
he in vitro and in vivo properties of NSCs. In general,
elected progenitor populations are highly stable, with
ome clones being serially passed for several years
ithout loss of their stem cell phenotype. Furthermore,
loned NSC lines have been obtained from a variety of
pecies including rats, mice, sheep, and humans.
Of considerable significance, genetically modified
SCs are engraftable and have been demonstrated to
ontinuously express foreign genes for extended periods
ithin the brain. They have been shown to be capable of
elivering therapeutic gene products in a widely dissem-
nated manner, cross-correcting host neurons and glia
hrough transcomplementation, and physically replacing
efective or dying neurons and glia, creating virtually
himeric regions of the brain (reviewed in Snyder, 1998).
pon transplantation into germinal zones, NSCs prolifer-
te briefly followed by migration throughout the brain
here they integrate in a cytoarchitecturally appropriate
anner and reside stably for variable periods up to the
ife of the animal. Engraftment is extensive when NSCs
re placed into the developing brain, but becomes in-
reasingly more restricted, and differentiation biased to-
0042-6822/00 $35.00
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228 MINIREVIEWward gliogenesis, as the brain matures. A particularly
fortuitous property of NSCs is that they are immunolog-
ically well tolerated after intracerebroventricular trans-
plantation, despite their modification with foreign genes
or transplantation into MHC-incompatible hosts. Even
xenotransplants, such as human NSCs, into the brains of
immunocompetent mice do not elicit an overt immune
response. This is likely to be due to the fact that the CNS
is an immunologically privileged site, although the spe-
cific mechanisms involved in NSC tolerance have not
been investigated.
An example of the extent to which NSCs can engraft
and distribute exogenous gene products is shown in Fig.
1 for the murine NSC clone C17-2 (Snyder et al., 1992).
Here C17-2 NSCs expressing b-galactosidase were in-
jected into the lateral cerebral ventricles of a neonatal
mouse. This mouse was sacrificed at 24 days of age and
FIG. 1. Distribution of engrafted NSCs and expression of a foreign ge
Representative coronal slices were taken periodically from a serially
immunostained for the expression of b-galactosidase (blue–black-sta
ransplanted NSCs. High-power outsets show the integration of the en
erebellar cortex. Although not illustrated, more robust engraftment into
ells into the fourth ventricle at birth.the brain sections were stained with an antibody to
b-galactosidase. While the distribution of engrafted cellsin this example is extensive, it should be noted that the
extent of NSC engraftment and its longevity can be vari-
able. The factors influencing persistence of transplanted
NSCs and the expression of exogenous genes by these
cells after transplantation are not yet known.
APPLICATION OF NSCs TO UNDERSTANDING
RETROVIRAL NEUROPATHOGENESIS
Murine oncornaviruses are simple retroviruses con-
taining three structural genes, gag, pol, and env, but,
unlike the complex retroviruses such as HIV and HTLV-1,
do not have multiply spliced accessory genes. These
viruses primarily induce proliferative diseases such as
leukemias, lymphomas, and carcinomas but may also
cause neurologic diseases if they enter the CNS. Genetic
mapping analyses indicate that the major determinants
r transplantation into the lateral ventricles of a neonatal mouse brain.
ned mouse brain 24 days posttransplantation with C17-2 NSCs and
ells). Note the extensive distribution throughout the neuroaxis of the
cells into the normal cytoarchitecture of the cerebral cortex and the
instem and spinal cord regions can be accomplished by transplantingne afte
sectio
ining c
graftedof murine retroviral neurovirulence reside in the env
gene, although other determinants located primarily out-
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229MINIREVIEWside the env have been shown to influence the tempo
nd severity of disease (reviewed in Portis and Lynch,
998).
The murine oncornaviruses have been demonstrated
o infect a number of cell types in the CNS. For example,
he infection of some populations of neurons which are
ostnatally mitotic can be readily detected at both pro-
ein and nucleic acid levels; however, these infected
eurons do not undergo degenerative changes. Although
here remains some controversy on this issue (Oldstone
t al., 1980), the neurons that do degenerate appear not
o be infected (discussed further in Portis and Lynch,
998). A variety of analyses indicate that neurodegenera-
ive changes specifically correlate with microglial infec-
ion (Portis and Lynch; 1998), and therefore the mecha-
ism by which virus mediates disease appears to be an
ndirect one. Viruses of the ecotropic host range group
ypically cause spongiform encephalomyelopathies
anifested clinically as paralysis and tremor, which
rogress to death. Viruses of the polytropic host range
roup cause primarily gliosis with signs of astroglial
egeneration, with disease being manifested clinically
s ataxia, which progresses to loss of mobility and
eath. For viruses carrying neurovirulent env genes, the
tempo and severity of the disease appear to correlate
with viral burden in the brain. Under normal circum-
stances, CNS viral burden is dictated by the ability of a
virus to replicate peripherally, reach high titers in the
blood, infect brain endothelia, and transit into the brain
parenchyma. This ability to enter the CNS at high levels
(neuroinvasiveness) is determined by both viral elements
influencing replication and host factors which restrict
infection of brain capillary endothelial cells (BCECs) (re-
viewed in Portis and Lynch, 1998). BCECs are permissive
to infection only until approximately postnatal day 10, and
this appears largely to account for the observation that
mice develop neurologic disease only when infected
during the neonatal or prenatal period.
Because of the various elements required for a virus to
enter the CNS, evaluating the neurovirulence of viruses
that are only weakly neuroinvasive has been difficult.
This problem, however, has been circumvented by the
recent application of NSCs as a transplantable virus
delivery system within the CNS parenchyma. To demon-
strate the efficacy of such an approach, the weakly neu-
roinvasive virus CasBrE was examined initially (Lynch et
al., 1996). CasBrE is an ecotropic oncornavirus originally
isolated from wild mice, which causes spongiform en-
cephalomyelopathy with low incidence and long incuba-
tion periods ranging from several months to over a year.
After neonatal intraperitoneal inoculation, the virus first
infects lymphohematopoietic organs such as spleen and
bone marrow and spreads as well to epithelial cells of
exocrine glands but infects the brain at very low levels.
Unfortunately, viral burden in the brain cannot be in-
creased by direct intracerebral inoculation. Therefore, to
t
lovercome the limited capacity for CNS infection by Cas-
BrE, the mouse NSC cell line C17-2 was infected in vitro.
The infection was found to be highly productive, but had
no adverse affects on the viability or phenotype of the
cells. After transplantation into the lateral cerebral
ventricles of neonatal mice, the cells readily engrafted,
migrated, and differentiated with an efficiency indistin-
guishable from that observed for uninfected NSCs. Un-
like intraperitoneally inoculated mice, these NSC-en-
grafted mice developed rapid, severe, and widespread
spongiosis that correlated with the extensive spread of
virus from NSCs to microglial cells of the recipient. This
represented then a “proof of principle” experiment which
demonstrated that NSCs can act as effective vehicles for
disseminating oncornavirus to the CNS and for precipi-
tating disease.
More recently, similar studies have been carried out
with polytropic viruses (Poulsen et al., 1999). In this case
a weakly neuroinvasive virus, Fr54, which was believed
to be avirulent, was found to induce clinical ataxia when
the brain was infected at high levels by implantation of
Fr54-infected NSCs. Thus, NSC-mediated delivery of vi-
rus to the parenchyma of the brain has the capacity for
revealing otherwise silent determinants of retroviral neu-
rovirulence and should further aid in identifying the spe-
cific env sequences involved in precipitating disease.
IS NEUROVIRULENT ENVELOPE PROTEIN
DIRECTLY NEUROTOXIC IN VIVO?
As indicated above, mapping studies have clearly
shown that the neurovirulence of both the ecotropic and
polytropic murine oncornaviruses is determined by the
sequence of the respective env genes. This point is
illustrated in Fig. 2 showing sections of the cerebral
cortex from mice infected with an avirulent virus (Friend
MuLV) and the highly neuropathogenic virus FrCasE,
which is identical to Friend MuLV except for its env gene
(derived from CasBrE). Both viruses infect large numbers
of microglial cells, but spongiform neurodegeneration is
only observed in the FrCasE -infected mice. This begs the
uestion, is the envelope protein directly neurotoxic
hen expressed in the brain? The neurotoxicity of HIV
p120 has been shown both through direct intracerebral
njection of the protein and through the generation of
ransgenic mice expressing HIV gp120 (SU) in the brain.
n the transgenic mice, dendritic paring and gliosis are
bserved that bear a striking resemblance to the neuro-
athology noted in humans with HIV-associated demen-
ia (Toggas et al., 1994). Unfortunately, similar transgenic
pproaches, attempting to express MuLV envelope
enes within the mouse brain, have been problematic,
rimarily due to an inability to obtain mice expressing
ignificant levels of neurovirulent env proteins, suggestinghe possibility of embryonic lethality (Portis et al., unpub-
ished observations; Kay et al., 1993; Yu et al., 1997).
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230 MINIREVIEWTo test the hypothesis that envelope protein is di-
rectly neurotoxic, the C17-2 NSC line was employed as
a means for obtaining high-level expression of a neu-
rovirulent oncornaviral envelope protein in the CNS
(Lynch et al., 1996). The cells were infected with a
retroviral expression vector carrying the CasBrE env
gene expressed as either the SU component alone
(analogous to the HIV-env transgenic) or SU in combi-
nation with the transmembrane domain (TM). In vitro
expression of the CasBrE–env constructs had no un-
toward effects on the survival or proliferation of the
NSCs, and since SU/TM combination is expressed on
the surface of these cells, a polyclonal population of
high expressers was easily obtained by fluorescence-
activated cell sorting. Engraftment resulted in wide-
spread distribution and differentiation of the engi-
neered NSCs into astrocytes, oligodendroglia, and
neurons. Furthermore, env gene expression was noted
throughout the brain and, most importantly, in regions
such as the deep cerebral cortex and thalamus which
are known to be highly vulnerable to the spongiform
degeneration induced by viruses carrying the CasBrE
env gene. In addition, the level of Env protein found in
the NSC engrafted brains was similar to that noted for
mice inoculated with the highly neuroinvasive chi-
meric virus FrCasE, a virus which induces uniformly
evere and rapidly fatal spongiform encephalomy-
lopathy (Fig. 2). Interestingly, no evidence of spongi-
sis was observed in response to the Env-expressing
SCs. This finding indicated that although the Env
rotein of CasBrE is an important determinant of neu-
FIG. 2. The influence of the viral env gene on neurovirulence. The ge
gene) is shown schematically above the photomicrographs (original
viruses infect microglial cells (cells with highly branched processes),
generation (holes seen in right panel) and paralysis which is rapidly fovirulence, the protein itself was not directly neuro-
oxic when overexpressed in the brain.
g
mDOES ENVELOPE-MEDIATED VIRAL FUSION
PRECIPITATE NEURODEGENERATION?
Because envelope protein normally acts to promote
irus fusion to target cells, an alternative mechanism by
hich envelope protein could mediate disease was in
he context of a fusigenic virus particle. To address the
ole of these early steps in the virus life cycle in oncor-
aviral neuropathogenesis, C17-2 NSCs were infected
ith a replication-competent neurovirulent virus contain-
ng the CasBrE env gene. The cells were transplanted
nto neonatal mice possessing the retrovirus resistance
ene Fv-1, which restricts replication of this virus at a
ostentry/preintegration stage of the virus life cycle. In
his way, the early steps of virus replication (i.e., binding,
usion, entry, and reverse transcription) could be evalu-
ted for their potential to cause disease in the absence
f an ongoing infection. Again, despite widespread ex-
ression of restricted virus by transplanted NSCs, spon-
iosis was not observed. In contrast, transplant of C17-2
ells containing virus that was not restricted by Fv-1
esulted in the appearance of spongiform neurodegen-
ration. In this latter group of mice, immunohistochemi-
al examination indicated that virus was expressed both
y NSC and by host microglia, whose infection had been
ound previously to be necessary and sufficient for the
nduction of spongiosis (Lynch et al., 1995). This obser-
ation was particularly relevant because microglial cells
re of mesodermal origin and thus constitute the only
ell population within the CNS parenchyma that is not
erived from NSCs. Because virus-expressing NSCs dif-
erentiated into neurons, astrocytes, and oligodendro-
tructure of two coisogenic viruses (differing in the sequence of the env
cation 1253). Sections were stained for viral envelope protein. Both
ly the virus containing env from CasBrE causes spongiform neurode-nome s
magnifilia, the lack of neuropathology in the Fv-1-restricted
ice provided strong evidence that late viral infection
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231MINIREVIEWevents occurring within microglial cells were required for
induction of neuropathology. The nature of the involve-
ment of microglia, however, is not clear. One possibility
is that posttranslational processing events specifically in
microglia could generate a species of viral envelope
protein with neurotoxic properties. Indeed, aberrant post-
translational products of the viral envelope protein are
expressed by microglial cells both in vitro (Lynch et al.,
994) and in vivo (Lynch and Sharpe, 2000). Alternatively,
nv expression alone in microglia may induce the re-
ease of a non-Env neurotoxin. In this way oncornavirus
europathogenesis might proceed by a mechanism
nalogous to that proposed for HIV (see the recent re-
iew by Gonzalez-Scarano and Baltuch, 1999).
IS MICROGLIAL EXPRESSION OF A
NEUROVIRULENT env GENE SUFFICIENT TO
INDUCE NEURODEGENERATION?
The studies described above offered ample evidence
hat infection of NSCs with replication-competent murine
ncornaviruses did not interfere with the engraftability of
he cells. These results suggested that if the NSCs were
onverted to retroviral packaging/producer cells, they
ight act as vehicles for the delivery of virtually any gene
o endogenous CNS cells. The notion of transplanting
ackaging/producer cells (i.e., the cells that provide the
tructural proteins for vector assembly) is not new; how-
ver, their usefulness in vivo has been limited by the
trong propensity of the engineered fibroblast cell lines
o become tumors in transplant recipients (Gage, 1998;
nyder and Senut, 1997). That NSCs can participate in
he normal development of many CNS regions at multiple
evelopmental stages provides the essential key to mak-
ng an engraftable CNS gene delivery system feasible.
To test this idea, C17-2 NSCs were engineered into a
ackaging cell line using a well-characterized ampho-
ropic MuLV packaging construct (Lynch et al., 1999). The
SC packaging/producer clones obtained were capable
f packaging a retroviral vector carrying the CasBrE
nvelope gene at titers up to 105 infectious units/ml.
nterestingly, the C17-2 NSCs, which already possess
wo defective retroviral expression vectors encoding Lac
/neo and v-myc/neo, do not efficiently package these
atter vectors into viral particles (100–2 infectious units/
l), despite the fact that they constitutively express b-ga-
lactosidase and exhibit factor-independent growth. This
property of selectively incorporating specific retroviral
vector transcripts obviated the need to perform these
experiments using growth factor-propagated primary
NSCs, although recent studies suggest that this can also
be accomplished (Lynch, unpublished observations). In
practice, transplantation of the packaging/producer
NSCs into the CNS resulted in lower level engraftment
than had been observed previously for engineered C17-2
NSCs. This result suggests that the selection procedureutilized can result in the inadvertent cloning of NSCs with
modified phenotypes. However, examination of the trans-
planted brains indicated that the CasBrE env gene had
been transferred to abundant host cells. Marker studies
demonstrated that a majority of the Env-expressing cells
were microglia. Interestingly, despite microglial expres-
sion of the complete CasBrE Env protein (SU and TM
components), no spongiosis was observed.
These results argue strongly that, while env gene
expression in microglial cells may be necessary, it is not
sufficient to induce neuropathology (see summary, Fig.
3). The results further imply that the expression of other
viral genes associated with viral particle assembly are
required for disease induction. It is of interest, in this
regard, that microglial cells infected with CasBrE env-
expressing viruses in vitro, exhibit aberrant virus bud-
ding into internal vesicular compartments and fail to
efficiently release infectious virus extracellularly (Lynch
et al., 1994). More recently, altered posttranslational pro-
cessing of the envelope protein and defective particle
release have been shown to correlate with the appear-
ance of spongiform neurodegeneration in vivo (Lynch
and Sharpe, 2000). Collectively, these observations imply
that the neuronal degeneration induced by murine on-
cornaviruses may be initiated by defective virus assem-
bly in microglial cells, specifically driven by structural
features of the viral envelope protein. The features that
are responsible for this behavior have not yet been
identified, but these mapping studies are in progress.
Although the nature of the neuronal insult in this dis-
ease is still unknown, it is clear from these studies that
an alteration of microglial function is likely to be involved.
Two alternative avenues for the induction of neurodegen-
eration are depicted schematically in a summary of the
NSC transplant studies (Fig. 3). These include the re-
lease of a neurotoxin (a gain of function; Fig. 3, upper
arrow) or the loss of a neurotrophic factor or support
function (Fig. 3, lower arrow). It is expected that defining
the specific microglial alterations induced by the pres-
ence of neurovirulent oncornaviruses should provide in-
sight into the normal relationship between neurons and
microglia and expand our understanding of other forms
of CNS pathology.
CONCLUSIONS
The construction of chimeric brains using NSC tech-
nology for selective reconstitution within the brain of
specific steps of the virus life cycle has provided impor-
tant clues as to the virus/host interactions involved in
oncornaviral neuropathogenesis. These experiments im-
plicate late steps in the virus life cycle occurring within
microglia and perhaps the alteration of normal microglial
physiology. In addition, these experiments provide a
“proof-of-principle” for the utility of NSC-based strategies
for virus-mediated gene delivery to the nervous system.
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232 MINIREVIEWIn its current form, NSC-based gene delivery utilizing
murine retroviral vectors has the limitation of requiring
cell division of the target cell. However, it should be
possible in the future to engineer NSCs with other gene
delivery systems that do not require cell division and
thus make feasible the efficient genetic alteration of
practically all cells of the CNS.
The approach outlined here represents a starting point
for the application of NSC technology for evaluating viral
neuropathogenesis. In light of a recent report indicating
the potential of NSCs to differentiate into hematopoietic
elements outside the CNS (see Bjornson et al., 1999), it
may be possible in the future to use NSCs for reconsti-
tuting CNS microglia. Alternatively, genetic manipulation
of ES cells followed by their differentiation toward hema-
topoietic, neuronal, or glial progenitors could be em-
ployed for reconstituting specific CNS elements. What-
ever the strategy, it is clear that the generation of chi-
meric brains through stem cell engraftment provides an
attractive alternative or adjunct to transgenic or knockout
technology for understanding how viruses interact within
the CNS to cause disease.
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